Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Fax+1 507-284-0161
Dr. Uhm is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGill University Faculty of MedicineClass of 1992, MD
Certifications & Licensure
MN State Medical License 1999 - 2027
WI State Medical License 2022 - 2024
TX State Medical License 1997 - 2004
Royal College of Physician of CanadaNeurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014-2017
Clinical Trials
- Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Publications & Presentations
PubMed
- Defining rapid early progression in glioblastoma-A volumetric approach.Vikram Munlapudi, Jacob Guzzino, David J Crompton, Shubhi Agarwal, Eric J Lehrer
Neuro-Oncology Advances. 2026-06-08 - Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of...Ugur Sener, Bryan Neth, Taylor Galloway, Heather Hughes, Samantha Caron
Contemporary Clinical Trials Communications. 2026-06-01 - Protocol for neuro-oncology anywhere 242: Pilot study evaluating telehealth and in-person assessments in patients with glioma receiving oral chemotherapy.Ugur Sener, Taylor Galloway, Bryan Neth, Joon Uhm, Sani H Kizilbash
Contemporary Clinical Trials Communications. 2026-02-01
Press Mentions
Beating Back a Brain Tumor Amid LossJune 17th, 2019
Experts Present How Science and New Technology Are Driving New Brain Tumor Treatments and Improving Quality of LifeJuly 23rd, 2015
Brain Cancer Survival Improved Following FDA Approval of Bevacizumab, Mayo Study FindsFebruary 10th, 2016
Grant Support
- Epidermal Growth Factor Receptor Signaling In GliomaNational Institute Of Neurological Disorders And Stroke2004–2006
- Soluble EGFR As A Potential Serum Biomarker In GliomaNational Cancer Institute2004
- Epidermal Growth Factor Receptor Signaling In GliomaNational Institute Of Neurological Disorders And Stroke2002–2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
